John Smither

Chief Financial Officer

CFO CFO Board Member

Executive compensation

Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.

Fiscal year	Company	Role	Salary	Bonus	Stock awards	Option awards	Incentive	Other	Total
2024	Arcutis Biotherapeutics, Inc. (ARQT)	Chief Financial Officer	$183,333	—	$1,053,771	$759,714	$105,600	—	$2,102,418
2023	Arcutis Biotherapeutics, Inc. (ARQT)	Chief Financial Officer	$200,886	—	—	$738,160	$97,179	—	$1,036,225
2021	Arcutis Biotherapeutics, Inc. (ARQT)	Chief Financial Officer	$100,000	—	$755,233	$5,384,317	—	$10,752	$6,250,292

Executive changes

Appointed Interim Chief Financial Officer at MBX Biosciences, Inc. (MBX)
2026-03-16
Appointed Class I Director at GENELUX Corp (GNLX)
2023-09-11
Appointed interim chief financial officer at Arcutis Biotherapeutics, Inc. (ARQT)
2023-08-31

Earnings-call appearances

Arcutis Biotherapeutics, Inc. Q4 FY2023 Earnings Call
Arcutis Biotherapeutics, Inc. (ARQT)

2024-02-27
Arcutis Biotherapeutics, Inc. Q3 FY2023 Earnings Call
Arcutis Biotherapeutics, Inc. (ARQT)

2023-11-03